Bay Colony Advisory Group Trims Stake in Merck & Co.
Bay Colony Advisory Group Inc., a financial institution, has adjusted its investment portfolio by selling shares of Merck & Co., Inc.
The institutional investor reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 33.4% during the second quarter, according to its latest 13F filing with the SEC.
This move resulted in Bay Colony Advisory Group Inc. owning 20,685 shares of the company's stock after selling 10,387 shares during the period.
The value of their holdings in Merck & Co., Inc. was $2,658,000 as of its most recent SEC filing.